Patents by Inventor John M. Molyneaux

John M. Molyneaux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyridine [3,4-b] pyrazinones
    Patent number: 7902195
    Abstract: Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: wherein R2, R6A, R6B and R8 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, synthetic methods, and intermediates are also disclosed.
    Type: Grant
    Filed: April 20, 2007
    Date of Patent: March 8, 2011
    Assignee: Pharmacia & Upjohn Company LLC
    Inventors: Robert O Hughes, Andrew Simon Bell, David Graham Brown, Dafydd Owen, Michael John Palmer, Christopher Phillips, David L. Brown, Yvette M. Fobian, John N. Freskos, Steven E. Heasley, E. Jon Jacobsen, Todd Maddux, Brent Mischke, John M. Molyneaux, Joseph B. Moon, D. Joseph Rogier, Jr., Michael B. Tollefson, John K. Walker
  • Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
    Publication number: 20040138261
    Abstract: Methods of treating cyclooxygenase-2 mediated disorders comprising administering to a subject a therapeutically effective amount of one or more fluoro-substituted benzenesulfonyl compounds corresponding to Formula I: 1
    Type: Application
    Filed: December 12, 2003
    Publication date: July 15, 2004
    Applicant: Pharmacia Corporation
    Inventors: David L. Brown, Matthew J. Graneto, Cindy L. Ludwig, John M. Molyneaux, John J. Talley
  • Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
    Patent number: 6699884
    Abstract: Methods of treating cyclooxygenase-2 mediated disorders comprising administering to a subject a therapeutically effective amount of one or more fluoro-substituted benzenesulfonyl compounds corresponding to Formula I: wherein A, X, n, R1, R2, and R3 are as described in the specification, and novel fluoro-substituted benzenesulfonyl compounds within Formula I.
    Type: Grant
    Filed: December 13, 2002
    Date of Patent: March 2, 2004
    Assignee: Pharmacia Corporation
    Inventors: David L. Brown, Matthew J. Graneto, Cindy L. Ludwig, John M. Molyneaux, John J. Talley
  • Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
    Patent number: 6673818
    Abstract: Methods of treating cyclooxygenase-2 mediated disorders comprising administering to a subject a therapeutically effective amount of one or more fluoro-substituted benzenesulfonyl compounds corresponding to Formula I: wherein A, X, n, R1, R2, and R3 are as described in the specification, and novel fluoro-substituted benzenesulfonyl compounds within Formula I.
    Type: Grant
    Filed: April 16, 2002
    Date of Patent: January 6, 2004
    Assignee: Pharmacia Corporation
    Inventors: David L. Brown, Matthew J. Graneto, Cindy L. Ludwig, John M. Molyneaux, John J. Talley
  • Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
    Publication number: 20030149078
    Abstract: Methods of treating cyclooxygenase-2 mediated disorders comprising administering to a subject a therapeutically effective amount of one or more fluoro-substituted benzenesulfonyl compounds corresponding to Formula I: 1
    Type: Application
    Filed: December 13, 2002
    Publication date: August 7, 2003
    Applicant: Pharmacia Corporation
    Inventors: David L. Brown, Matthew J. Graneto, Cindy L. Ludwig, John M. Molyneaux, John J. Talley
  • Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
    Publication number: 20030032657
    Abstract: Methods of treating cyclooxygenase-2 mediated disorders comprising administering to a subject a therapeutically effective amount of one or more fluoro-substituted benzenesulfonyl compounds corresponding to Formula I: 1
    Type: Application
    Filed: April 16, 2002
    Publication date: February 13, 2003
    Applicant: Pharmacia Corporation
    Inventors: David L. Brown, Matthew J. Graneto, Cindy L. Ludwig, John M. Molyneaux, John J. Talley
  • Production of phosphonopyrazoles
    Publication number: 20020107401
    Abstract: Novel compounds with activity as chemical hybridizing agents and methods for synthesis of such compounds are disclosed. These compounds are useful in producing hybrid wheat (Triticum aesativum) and other crops.
    Type: Application
    Filed: August 1, 2001
    Publication date: August 8, 2002
    Applicant: MONSNTO TECHNOLOGY LLC.
    Inventors: Paula C. Miller, Jane M. Curtis, John M. Molyneaux, Thomas J. Owen
  • Production of phosphonopyrazoles
    Patent number: 6297194
    Abstract: Pyrazole compounds with activity as chemical hybridizing agents and methods for synthesis of such compounds are disclosed. These compounds are useful in producing hybrid wheat (Triticum aesativum) and other crops.
    Type: Grant
    Filed: February 2, 2000
    Date of Patent: October 2, 2001
    Assignee: Monsanto Technology, LLC
    Inventors: Paula C. Miller, Jane M. Curtis, John M. Molyneaux, Thomas J. Owen
  • Substituted 2,6-substituted 1,2- or 1,6-dihydro pyridine compounds
    Patent number: 4908057
    Abstract: Disclosed herein are dihydropyridine dicarboxylic acid amide derivatives which are useful as herbicides, and herbicidal compositions and methods using same.
    Type: Grant
    Filed: August 1, 1988
    Date of Patent: March 13, 1990
    Assignee: Monsanto Company
    Inventors: John P. Chupp, Len F. Lee, William F. Goure, John M. Molyneaux